Search Results - "Kala, Jaya"

Magnesium: An Overlooked Electrolyte by Kala, Jaya, MD, Abudayyeh, Ala, MD

“…Abstract Background Hypermagnesemia is rare and usually iatrogenic. Due to decreased renal function, older patients are generally more susceptible to…”
Get full text

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma by Ratanasrimetha, Praveen, Reddy, Vikas D, Kala, Jaya, Tchakarov, Amanda, Glass, William F, Msaouel, Pavlos, Lin, Jamie S

“…Diagnosing immune checkpoint inhibitor (ICI)-associated nephritis can be challenging since it is a rare complication of therapy, associated with a spectrum of…”
Get full text

Eruptive Xanthoma by Kala, Jaya, Mostow, Eliot N

“…A 30-year-old woman with diabetes who had poor glucose control, hypertension, and hyperlipidemia was referred for evaluation of a rash of 1 month's duration…”
Get full text

Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma by Hamad, Christopher D., Hoelscher, Zachary C., Tchakarov, Amanda, Kala, Jaya

“…Thrombotic microangiopathy (TMA) in a cancer patient is a common complication of either cancer itself or anticancer therapy. Incidence of TMA from anticancer…”
Get full text

Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin by Pankow, Jonathan D., Richard-Carpentier, Guillaume, Daver, Naval G., Glass, William F., Kala, Jaya

“…We present a 61-year-old male with FLT3 -mutated acute myeloid leukemia treated with midostaurin who developed acute kidney injury requiring hemodialysis and…”
Get full text

Evans Syndrome and Granulomatosis With Polyangiitis: An Interesting Concomitant Occurrence by Sahay, Sandeep, MD, Paik, Rajandeep, MD, Kala, Jaya, MD, Kanaan, Ziad, MD

Get full text

Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis by Shah, Ashok, MD, Kala, Jaya, MBBS, Sahay, Sandeep, MD, Panjabi, Chandramani, MD

“…Background Asthma is known to run in families. Allergic bronchopulmonary aspergillosis (ABPA) occurs predominantly in patients with asthma. However, there are…”
Get full text

Radiation-induced kidney injury by Kala, Jaya

“…Renal dysfunction because of radiation exposure was recognized decades ago. The incidence declined when more effective chemotherapeutic agents became…”
Get full text

Dietary Hyperuricemia Causes Nephropathy in a Cancer Patient: PO0216 by Ali, Aliasger A., Bejjanki, Harini, Kala, Jaya

Get full text

Selinexor-Associated Hyponatremia: Single-Center Real-World Data: PO2175 by Mamlouk, Omar, Jhaveri, Kenar D., Kala, Jaya

Get full text

Pembrolizumab-Induced Acral Vasculitis by Yohannan, Binoy, Truly, Tate, Kala, Jaya, Jafri, Syed Hasan

“…Immune checkpoint inhibitors (ICIs) have emerged as groundbreaking new therapies for a variety of solid tumors. ICIs stimulate the host immune system to attack…”
Get full text

Pembrolizumab-Induced Acral Vasculitis by Yohannan, Binoy, Truly, Tate, Kala, Jaya, Jafri, Syed Hasan

“…Immune checkpoint inhibitors (ICIs) have emerged as groundbreaking new therapies for a variety of solid tumors. ICIs stimulate the host immune system to attack…”
Get full text

Onconephrology by Kala, Jaya, Finkel, Kevin W.

“…Current advances in cancer chemotherapeutics have remarkably helped in rapid and definitive treatment options. However, these potent chemotherapeutics have…”
Get full text

AKI Associated with Anti-cancer Therapies: Small Molecules and Targeted Therapies by Kala, Jaya, Joseph, Teresa, Pirovano, Marta, Fenoglio, Roberta, Cosmai, Laura

“…Molecular targeted therapy has revolutionized cancer treatment by significantly improving the patient survival compared to standard conventional…”
Get full text

Paroxysmal Nocturnal Hemoglobinuria Presenting with Hemorrhagic Esophageal Varices by Wilson, Nathaniel R., Abbas, Hussein A., Kala, Jaya

Get full text

Treatment of PLA2R-Negative Membranous Nephropathy in the Setting of Immune Checkpoint Inhibitor and Renal Cell Carcinoma: PO1868 by Reddy, Vikas D., Kala, Jaya, Msaouel, Pavlos S., Glass, William F., Mamlouk, Omar, Abudayyeh, Ala, Lin, Jamie S.

Get full text

Spontaneous Page kidney from ruptured renal angiomyolipoma by Neela, Niharika, Taha, Hula, Kala, Jaya

“…Renal angiomyolipomas are the most common benign tumors of the kidneys. They are prone to rupture, which may result in massive hemorrhage and often requires…”
Get full text

Renal lymphomatous infiltration by mantle cell lymphoma: Treatment with chemoradiation and initiation of angiotensin converting enzyme (ACE) inhibitor for renal protection by Damron, Ethan P, Gunther, Jillian R, Kala, Jaya

“…Background: Mantle Cell Lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma (NHL) that often takes an aggressive course. Rarely, MCL may cause acute…”
Get full text

Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON) by Kitchlu, Abhijat, Silva, Verônica T Costa E, Anand, Shuchi, Kala, Jaya, Abudayyeh, Ala, Inker, Lesley A, Rosner, Mitchell H, Karam, Sabine, Gudsoorkar, Prakash, Gupta, Shruti, Chen, Sheldon, Klomjit, Nattawat, Leung, Nelson, Milanez, Tomaz, Motwani, Shveta S, Khalid, Sheikh B, Srinivasan, Vinay, Wanchoo, Rimda, Beumer, Jan H, Liu, Geoffrey, Tannir, Nizar M, Orchanian-Cheff, Ani, Geng, Yimin, Herrmann, Sandra M

Get more information

Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology by Kitchlu, Abhijat, Silva, Verônica T Costa E, Anand, Shuchi, Kala, Jaya, Abudayyeh, Ala, Inker, Lesley A, Rosner, Mitchell H, Karam, Sabine, Gudsoorkar, Prakash, Gupta, Shruti, Chen, Sheldon, Klomjit, Nattawat, Leung, Nelson, Milanez, Tomaz, Motwani, Shveta S, Khalid, Sheikh B, Srinivasan, Vinay, Wanchoo, Rimda, Beumer, Jan H, Liu, Geoffrey, Tannir, Nizar M, Orchanian-Cheff, Ani, Geng, Yimin, Herrmann, Sandra M

“…Accurate assessment of GFR is crucial to guiding drug eligibility, dosing of systemic therapy, and minimizing the risks of both undertreatment and toxicity in…”
Get more information